Whereas the protective effect of cannabinoids on murine atherosclerosis progression has been studied [17], it is not known whether our findings decreased NFκB signaling, and decreased scavenger receptor levels, causally explains the previously reported in vivo findings. The gene discussed is NFKB1; the disease is atherosclerosis.